Canadian Metabolomic Technologies Secures $4.2M Series A Financing Round
October 21, 2019 12:00 ET
|
Metabolomic Technologies Inc.
EDMONTON, Alberta, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Metabolomic Technologies Inc. (MTI), a Canadian-based company developing metabolomics-based in vitro diagnostics today announced the successful...
Alberta to begin assessing a new colorectal cancer screening strategy using Metabolomic Technologies’ PolypDx™
October 22, 2018 08:00 ET
|
Metabolomic Technologies Inc.
PolypDx™ is the first and only urine-based test with a high sensitivity for detection of precancerous polyps EDMONTON, Alberta, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Metabolomic Technologies Inc....